Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan
ConclusionsThis large-scale survey showed that molnupiravir was safe and effective in real-world settings in highly vaccinated Japanese patients with COVID-19, including older patients and those with comorbidities.
Source: Infectious Diseases and Therapy - Category: Infectious Diseases Source Type: research
More News: Coronavirus | Covid Vaccine | COVID-19 | Drugs & Pharmacology | Emergency Medicine | Infectious Diseases | Japan Health | Vaccines